Meta AnalysisID 6096
复方丹参滴丸治疗糖尿病视网膜病变：随机临床试验系统评价与Meta分析方案
CRD42021225877
In order to make a protocol about analyzing the efficiency and safety of Compound Danshen Dripping Pills for Diabetic Retinopathy.
Relationship Network
Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.
Click a node to open it in a new tab
Formula: 1Meta-analysis: 1Links: 1
Arranging relationship network...
Record Fields
Scalar fields from the final meta_analysis record.
- Meta Analysis Id
- 6096
- Evidence Id
- 14654
- Core Evidence Id
- 14654
- Source Meta Analysis Id
- 6078
- Herb2 Meta Analysis Id
- HBMA006078
- Crd Id
- CRD42021225877
- Title
- Compound Danshen Dripping Pills For Diabetic Retinopathy: A Protocol of Systematic Review and Meta-analysis of Randomized Clinical Trials
- Review Question
- In order to make a protocol about analyzing the efficiency and safety of Compound Danshen Dripping Pills for Diabetic Retinopathy.
- Study Type Included
- RCTs
- Condition Being Studied
- Diabetic retinopathy is a common microvascular complication in diabetic patients, and it is also one of the main diseases that cause blindness. It causes severe mental and economic pressure on patients and their families. Clinical studies have shown that compound Danshen dripping pills are effective in the treatment of diabetic retinopathy, but the safety and effectiveness have not been effectively confirmed.
- Participant
- Patients diagnosed with diabetic retinopathy, regardless of guidelines.
- Animal
- Human Disease Modelled
- Intervention
- Intervention measures are compound Danshen dripping pills or compound Danshen dripping pills combined with other drugs.
- Comparator Control
- The control group chooses conventional treatment or placebo for diabetic retinopathy
- Main Outcome
- Blood glucose level (2 h postprandial blood glucose, fasting blood glucose, glycosylated hemoglobin); Visual field gray value, hemangioma body, macular thickness ，bleeding spot area Measures of effect We will measure continuous data with a mean difference or standardized mean difference for the therapeutic effect with 95% confidence intervals. For dichotomous data, risk ratios with 95% confidence intervals will be calculated.
- Outcome Measure
- Additional Outcome
- vision or Platelet function (Maximum platelet aggregation rate MAR, platelet alpha granule membrane protein 140 GMP-14, platelet electrophoresis rate) Measures of effect We will measure continuous data with a mean difference or standardized mean difference for the therapeutic effect with 95% confidence intervals. For dichotomous data, risk ratios with 95% confidence intervals will be calculated
- Study Method
- Systematic review, Other
- Keyword
- Diabetes Mellitus; Diabetic Retinopathy; Drugs, Chinese Herbal; Humans; Meta-Analysis as Topic; Randomized Controlled Trials as Topic; Salvia miltiorrhiza; Systematic Reviews as Topic; danshen dripping pill
- Contact
- Xiaoying Huang [email protected]
- Organisational Affiliation
- Hospital of Chengdu University of TCM
- Funding Source
- No funding sources.
- Other Selection Criteria
- Final Publication
- Same Topic Review
- Published Protocol
- Review Type
- Language
- English
- Country
- China
- Review Stage
- Review Ongoing
- First Submission Date
- 2020-12-12
- Registration Date
- 2021-01-12
- Anticipated Start Date
- 2020-12-15
- Anticipated Completion Date
- 2021-05-25
- Title Cn
- 复方丹参滴丸治疗糖尿病视网膜病变：随机临床试验系统评价与Meta分析方案
- Title En
- Compound Danshen Dripping Pills For Diabetic Retinopathy: A Protocol of Systematic Review and Meta-analysis of Randomized Clinical Trials
- Bilingual Status
- complete